Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Analyst Ratings
Downgrades
News
BTIG Downgrades Medtronic to Neutral
BTIG analyst Sean Lavin downgrades Medtronic (NYSE:MDT) from Buy to Neutral.
by
Benzinga Newsdesk
January 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
BTIG analyst Sean Lavin downgrades Medtronic (NYSE:
MDT
) from Buy to Neutral.
Total
0
Shares
Share
0
Tweet
0
Share
0
Share
0
Share
0
Share
0